Zargis Medical, a majority-owned subsidiary of Speedus Corp, has signed an agreement with the Ontario Telemedicine Network (OTN) to provide the delivery and testing of Zargis' telemedicine stethoscope system Zargis TeleSteth.
Zargis TeleSteth, the core component of Zargis’ telemedicine stethoscope system, is a component of the Zargis Cardioscan heart sounds analysis software and the Zargis StethAssist heart and lung sounds visualization software.
Zargis TeleSteth permits patient sounds to be remotely evaluated in real-time (synchronous) or store-and-forward (asynchronous) mode.
Additionally, for organisations requiring users to access stethoscope sounds from within their private network, TeleSteth can be deployed using Zargis’ secure enterprise server platform.
Zargis CEO John Kallassy said that Zargis’ tele-auscultation platform will help OTN deliver cost-effective, expert healthcare and they are pleased to have been selected as the vendor of tele-auscultation solutions for their vast network of healthcare professionals throughout Canada’s most populous province.
OTN CEO Ed Brown said that OTN depends on reliable and easy-to-use equipment and Zargis’ expertise in the field and the quality of their product met their need for a superior telemedicine stethoscope solution.
Zargis is majority-owned by Speedus Corp and both 3M Company and Siemens Corporate Research, a division of Siemens AG, hold equity positions.